A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...
The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...
The Food and Drug Administration recently expanded approval for Spravato, an antidepressant nasal spray used to treat ...
The Food and Drug Administration (FDA) recently gave approval for clinical trials in the U.S. of a COVID-19 nasal vaccine ...
THREE of the most dangerous medicines in the world have been revealed – and millions of Brits already use them. A cold and ...
Ketamine has been used as an anesthetic before surgeries for decades, but it can also be an option for those struggling with ...
The use of ketamine to treat severe depression was approved in Singapore in October 2020, to be administered as a nasal spray together with oral anti-depressant therapy. Clinical trials have shown ...
ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.
A doctor with the Louisville Metro Department of Public Health and Wellness says the large flu outbreak happening across ...
WHEN doctors asked Curtis Arnold-Harmer how long he’d been using cocaine, the 29-year-old was baffled. “I’ve never touched ...
In a Phase IIb trial, GH001 elicited significant drops in treatment-resistant depression. The news comes less than two weeks ...
The US Patent and Trademark Office (USPTO) has granted a patent to Vistagen’s non-opioid oral product candidate, AV-101 for ...